General
About Company
Related to
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that develops and commercializes innovative medicines.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
Arisaph Pharmaceuticals
Arisaph Pharmaceuticals develops targeted therapies for cancer, cardiovascular disease, and diabetes.
Sector
Subsector
Location
total rounds
total raised
Reata Pharmaceuticals
Reata Pharmaceuticals develops novel therapeutics for serious diseases.
Sector
Subsector
Location
total rounds
total raised
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals is developing targeted medicines for cancer and other proliferative diseases.
Sector
Subsector
Location
total rounds
total raised
ArgiNOx Phamaceuticals
Arginox Pharmaceuticals is a biopharmaceutical company focused on discovering and developing drugs for cardiovascular diseases.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Gilead Sciences
announced date
price
Financials
Funding Rounds1
Number of Funding Rounds
Their latest funding was raised on 01.01.1991. Their latest investor Frazier Healthcare Partners. Their latest round Undisclosed
Co-Investors
Investors1
Number of lead investors
Number of investors
Frazier Healthcare Partners
Frazier Healthcare Partners is a private equity firm that provides growth and venture capital to healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Peter Milner
Peter cofounded Optivia Biotechnology a leading transporter biology company. In 1997 Peter co-founded ARYx Therapeutics (NASDAQ: ARYX) whereas CEO then as president from 2005 to 2010 he co-invented and developed 4 novel drugs. In 1990 he co-founded CV Therapeutics (NASDAQ: CVTX), whereas a member of senior management from 1992-to 1996 he in-licensed and invented several successful pharmaceuticals.
current job
organization founded
Peter Milner
Employee Profiles115
Elfatih Elzein
Senior scientist at cv therapeutics inc
Michael Burdick
Project Management Leadership Positions
Allene Dodge
Senior Director. Regulatory Affairs & Quality Assurance
Carol Karp
Senior Vice President, Regulatory Affairs, Quality and Drug Safety
